A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease

por McArthur, James G., Svenstrup, Niels, Chen, Chunsheng, Fricot, Aurelie, Carvalho, Caroline, Nguyen, Julia, Nguyen, Phong, Parachikova, Anna, Abdulla, Fuad, Vercellotti, Gregory M., Hermine, Olivier, Edwards, Dave, Ribeil, Jean-Antoine, Belcher, John D., Maciel, Thiago T.
Publicado 2020